Prospective Observational Cohort Study of Tenecteplase: Results From the Indian Registry in Ischemic Stroke‐Tenecteplase

Prospective Observational Cohort Study of Tenecteplase: Results From the Indian Registry in Ischemic Stroke‐Tenecteplase

Background Tenecteplase has been approved for acute ischemic stroke at a dose of 0.2 mg/kg by the Indian licensing authority. A registry to evaluate the safety of tenecteplase was mandated by the licensing authority. The research aim was to use the Indian Registry in Ischemic Stroke‐Tenecteplase (IR...

Full description

Saved in:
Bibliographic Details
Main Authors: Amit Saraf, Percival C. Gilvaz, Tirppur C. R. Ramakrishnan, R. N. Komal Kumar, Salvadeeswaran Meenakshi‐Sundaram, Santosh M. Sontakke, Anand Alurkar, Somasundaram Kumaravelu, Pamidimukkala Vijaya, Mangesh Udar, Deepak Arjundas, Soaham Desai, Mukesh Sharma, Suresh BV, Rithesh R. Nair, Sadique Pathan, Shripad S. Pujari, Sudhir Kumar, Keyur Machhavada, Jayantee Kalita, Usha K. Misra, Bhalchandra Vaidya, Leonid Churilov, Mark W. Parsons, Sanjay Singh
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute ischemic stroke
hemorrhages
standard of care
tenecteplase
thrombolytic therapy
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.036382
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items